MMI SpA Touts World's Smallest Wristed Surgical Instruments
October 28, 2020
MMI SpA, an Italian company dedicated to improving clinical outcomes for
patients undergoing microsurgery, launched its CE Mark
and noted the first human use of its Symani Surgical System in Europe for open
microsurgical procedures. The first four robotic surgeries were
successfully performed in Florence, Italy, including three complex,
post-traumatic lower limb reconstructions as well as a post-oncological
reconstruction of the pharynx.
MMI’s Symani Surgical System for Robotic Microsurgery
"There is a clear demand for robotics in microsurgery as the limits of
the human hand have already been reached. We founded MMI to develop a
robotic system designed for and with microsurgeons that will improve
outcomes and address unmet patient needs, particularly through
supermicrosurgery techniques which are required for lymphatic and other
extremely delicate procedures. We are pleased to be at the forefront of
a new era in robotic surgery as we launch our Symani System in Europe,"
said Giuseppe Maria Prisco, co-founder and CEO of MMI.
The Symani Surgical System combines the benefits of tremor reduction and
motion scaling (7-20x) with the world's smallest wristed
instrumentation, offering seven degrees of freedom and dexterity beyond
the reach of human hands. The system's NanoWrist® instruments are
designed to overcome the challenges of free-flap reconstructions,
replantations, congenital malformations, peripheral nerve repairs and
lymphatic surgery, which together represent over one million procedures
annually in the U.S. and Europe alone.
and supermicrosurgery – as a tool, technique and discipline – continue
to evolve. The use of robotics holds great promise to advance the
specialty of microsurgery and improve care for patients affected by
trauma, cancer, congenital malformations and even chronic conditions
such as lymphedema," commented L. Scott Levin, MD, FACS, FAOA, Chair of
the Department of Orthopaedic Surgery, Professor of the Plastic Surgery
Division at the University of Pennsylvania School of Medicine.
"We are proud to bring this innovation to European patients and look
forward to enabling surgeons worldwide to address challenging procedures
on extremely small anatomy with increased precision, reproducibility and
efficiency," said Hannah Teichmann, co-founder and Vice President of
Clinical Development of MMI.